Winner Medical Co., Ltd. (300888.SZ)
CNY 43.5
(-2.33%)
CNY 43.5
(-2.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 817.96 Million CNY | -67.0% |
| 2022 | 1.97 Billion CNY | 33.95% |
| 2021 | 1.47 Billion CNY | -67.44% |
| 2020 | 4.53 Billion CNY | 606.13% |
| 2019 | 641.77 Million CNY | 29.46% |
| 2018 | 495.71 Million CNY | -3.95% |
| 2017 | 516.12 Million CNY | 4.89% |
| 2016 | 492.06 Million CNY | 95.83% |
| 2015 | 251.26 Million CNY | 65.98% |
| 2014 | 151.38 Million CNY | 57.94% |
| 2013 | 95.84 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 164.4 Million CNY | 173.17% |
| 2024 Q3 | 172.31 Million CNY | 9.74% |
| 2024 Q2 | 191.37 Million CNY | 16.4% |
| 2023 Q1 | 452.7 Million CNY | -8.12% |
| 2023 Q4 | -224.67 Million CNY | -112.93% |
| 2023 FY | 652.33 Million CNY | -67.0% |
| 2023 Q3 | 1.73 Billion CNY | 374.18% |
| 2023 Q2 | 366.57 Million CNY | -19.03% |
| 2022 Q4 | 492.74 Million CNY | 13.5% |
| 2022 Q3 | 434.12 Million CNY | -30.61% |
| 2022 Q2 | 625.63 Million CNY | 47.54% |
| 2022 Q1 | 424.04 Million CNY | 113.28% |
| 2022 FY | 1.97 Billion CNY | 33.95% |
| 2021 FY | 1.47 Billion CNY | -67.44% |
| 2021 Q3 | 366.25 Million CNY | 9.69% |
| 2021 Q4 | 198.81 Million CNY | -45.72% |
| 2021 Q1 | 576.66 Million CNY | -30.59% |
| 2021 Q2 | 333.9 Million CNY | -42.1% |
| 2020 Q2 | 834.9 Million CNY | 118.65% |
| 2020 FY | 4.53 Billion CNY | 606.13% |
| 2020 Q1 | 381.84 Million CNY | 136.44% |
| 2020 Q3 | 2.48 Billion CNY | 197.53% |
| 2020 Q4 | 830.86 Million CNY | -66.55% |
| 2019 Q4 | 161.5 Million CNY | -22.83% |
| 2019 FY | 641.77 Million CNY | 29.46% |
| 2019 Q3 | 209.28 Million CNY | 54.15% |
| 2019 Q2 | 135.77 Million CNY | -0.0% |
| 2019 Q1 | 135.77 Million CNY | 0.0% |
| 2018 FY | 495.71 Million CNY | -3.95% |
| 2017 FY | 516.12 Million CNY | 4.89% |
| 2016 FY | 492.06 Million CNY | 95.83% |
| 2015 FY | 251.26 Million CNY | 65.98% |
| 2014 FY | 151.38 Million CNY | 57.94% |
| 2013 FY | 95.84 Million CNY | 0.0% |